Global /Australia /Healthcare /Drug Manufacturers - Specialty & Generic /VLS

Vita Life Sciences Ltd.

VLS

• ASX: VLS • Delayed

2.53AUD -1.9%

1.81 USD

As of 5 June 2026, Vita Life Sciences Ltd. has a market cap of $100.03M USD, ranking #25565 globally and #588 in Australia. It ranks #2292 in the Healthcare sector, and #119 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

25565

Country Rank

588

Sector Rank

2292

Industry Rank

119

Key Stats

Market Cap

$100.03MUSD

140.17M AUD

Enterprise Value

$76.29MUSD

106.91M AUD

Revenue (TTM)

$66.56MUSD

93.27M AUD

EBITDA (TTM)

$10.38MUSD

14.55M AUD

Net Income (TTM)

$7.45MUSD

10.44M AUD

EBITDA Margin

16%

Profit Margin

11%

PE Ratio

14.1

PS Ratio

1.5

PB Ratio

2.5

EV/EBITDA

7.1

Company Profile

Country (HQ)

Australia

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Andrew O'Keefe open_in_new

Employees

350

Founded

1947

Website

vitalifesciences.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.9%	2.4%	-0.8%	-3.4%	9.3%	-0.8%	47%	76%	130%

News

Markets

Exchange	Ticker	Price	Quotes
Australian Securities Exchange (ASX) MIC: XASX PRIMARY	VLS Vita Life Sciences Ltd ISIN: AU000000VLS8 Shares Out.: Shares Outstanding: 53.167M¹ Shares Float: 12.847M² TV: TradingView: ASX: VLS SA: Stock Analysis: ASX: VLS YF: Yahoo Finance: VLS.AX GF: Google Finance: ASX: VLS BA: Barron's: VLS MS: Morningstar: XASX: VLS	2.53 AUD	TV: TradingView: ASX: VLS SA: Stock Analysis: ASX: VLS YF: Yahoo Finance: VLS.AX GF: Google Finance: ASX: VLS BA: Barron's: VLS MS: Morningstar: XASX: VLS

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Vita Life Sciences Ltd.

Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. The company offers various minerals, herbs, and superfoods. It markets its products through pharmacies and health food channels under the Herbs of Gold, VitaHealth, and VitaScience brands. Vita Life Sciences Limited was founded in 1947 and is headquartered in Mascot, Australia.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (Australia)

Name	Market Cap (USD) diff.	PE	Country
Neuren Pharmaceuticals Ltd. ASX: NEU	$1.11B 1.55B AUD 1K%	52.7	Australia
Actinogen Medical Ltd. ASX: ACW	$123.03M 172.39M AUD 23%	-	Australia
Clover Corporation Ltd. ASX: CLV	$114.37M 160.26M AUD 14%	18.1	Australia
Paradigm Biopharmaceuticals Ltd. ASX: PAR	$56.42M 79.06M AUD -44%	-	Australia
Beroni Group Ltd. OTCMKTS: BNIGF	$49.41M -51%	-	Australia
Next Science Ltd. ASX: NXS	$30.28M 42.43M AUD -70%	-	Australia

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$37.66B 108.92B ILS 38K%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 29K%	-	United States
Zhejiang NHU Company Ltd. SHE: 002001	$15.86B 107.34B CNY 16K%	16.0	China
Cipla Ltd. NSE: CIPLA	$11.12B 1.06T INR 11K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.0B 1.05T INR 11K%	22.7	India
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.1B 61.6B CNY 9K%	80.6	China

chevron_leftBack